1. Abdel-Maksoud, Mostafa A, Ullah, Sajid, Nadeem, Amun, Al-Qahtani, Wahidah H, Hameed, Yasir. 2023. PTPN3 in cancer: unveiling its immune-mediated impact on prognosis and dysregulated signaling pathways. In American journal of translational research, 15, 6464-6475. doi:. https://pubmed.ncbi.nlm.nih.gov/38074816/
2. Zhou, Ziting, Lin, Zhengjun, Wang, Mingrui, Zhu, Guanghui, Liu, Tang. 2024. Identification and verification of PTPN3 as a novel biomarker in predicting cancer prognosis, immunity, and immunotherapeutic efficacy. In European journal of medical research, 29, 12. doi:10.1186/s40001-023-01587-5. https://pubmed.ncbi.nlm.nih.gov/38173048/
3. Li, Shuqin, Cao, Jian, Zhang, Wei, Tao, Xiang, Xia, Hongping. 2016. Protein tyrosine phosphatase PTPN3 promotes drug resistance and stem cell-like characteristics in ovarian cancer. In Scientific reports, 6, 36873. doi:10.1038/srep36873. https://pubmed.ncbi.nlm.nih.gov/27833130/
4. Yan, Qianqian, Zhao, Zihao, Liu, Dongwei, Dong, Jiancheng, Liu, Zhangsuo. 2022. Integrated analysis of potential gene crosstalk between non-alcoholic fatty liver disease and diabetic nephropathy. In Frontiers in endocrinology, 13, 1032814. doi:10.3389/fendo.2022.1032814. https://pubmed.ncbi.nlm.nih.gov/36387855/
5. Peng, Xing-Si, Yang, Jun-Ping, Qiang, Yuan-Yuan, Huang, Bi-Jun, Qian, Chao-Nan. 2020. PTPN3 Inhibits the Growth and Metastasis of Clear Cell Renal Cell Carcinoma via Inhibition of PI3K/AKT Signaling. In Molecular cancer research : MCR, 18, 903-912. doi:10.1158/1541-7786.MCR-19-1142. https://pubmed.ncbi.nlm.nih.gov/32169891/
6. Wu, Chew-Wun, Chen, Jen-Hao, Kao, Hwa-Li, Chi, Chin-Wen, Lin, Wen-Chang. . PTPN3 and PTPN4 tyrosine phosphatase expression in human gastric adenocarcinoma. In Anticancer research, 26, 1643-9. doi:. https://pubmed.ncbi.nlm.nih.gov/16619586/
智鼠故事 
